You must log in to view this page.

BridgeBio Pharma Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: BBIO
Share price (8/11/26): $83.70
Market cap (8/11/26): $16.4 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Google Finance
SEC EDGAR

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1

from 8-K 80 pages Agreement and Plan of Merger by and Among Eidos Therapeutics, Inc., BridgeBio Pharma, Inc. Globe Merger Sub I, Inc. and Globe Merger Sub II, Inc. Dated as of October 5, 2020

12/34/56